Home Visit
Upload
.png)
Alzheimer Disease Screening Profile
52+ booked in last 3 days
No special precautions
Recommended for
Male, Female
Report
Within 24 Hours
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Alzheimer’s disease is the most common cause for dementia leading to gradual decline in memory, thinking ability, cognitive skills and daily activities. This may in turn also affect the mood, behaviour and social skills of the patient. Alzheimer’s most commonly occurs beyond 65 years, although in certain rare cases it may occur in patients <50 years (Early onset Alzheimer’s). The most common cause for Alzheimer’s is deposition of certain proteins known as amyloid proteins in the brain cells. Alzheimer disease screening profile CSF is often used along with the routine clinical examination and other tests for diagnosis of Alzheimer’s disease.
*Sample collection is done by qualified healthcare providers within hospital or clinic settings. The lab is only responsible for the analysis and processing of the sample.
Written by - Dr. Shibani R, Medical Writer, Medical Affairs
Alzheimer Disease Screening Profile Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Alzheimer Disease Screening Profile with a clear pricing structure.
The Alzheimer Disease Screening Profile Price in Mumbai is ₹ 13,250 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Alzheimer disease screening profile CSF measure levels of beta-amyloid protein and tau protein in the CSF sample.
- Although the provisional diagnosis of Alzheimer’s is majorly done based on the patient’s symptoms and radiological examination, the laboratory tests and CSF examination may further aid the diagnosis.
- The test may be done for early diagnosis of suspected Alzheimer's disease.
- To differentiate between Alzheimer’s induced dementia and vascular causes for dementia.
It is advised that patients with the following clinical signs and symptoms of Alzheimer’s should undergo testing for differential diagnosis:
- Memory loss or dementia (mainly recent or short term memory)
- Delayed thinking or processing skills
- Reduced cognition
- Difficulty reasoning and handling complex tasks.
- Language processing difficulties.
- Understanding visual form and space relationship.
- Changes in overall behavior and personality.
This test requires a CSF sample. A spinal needle is used and the patient's CSF sample is collected with the necessary aseptic precautions.
No special precautions are required.
The levels of beta-amyloid protein and tau protein in the CSF sample aids the diagnosis and to determine the prognosis.
Determination of beta-amyloid (1-42) with total tau or p-tau in the CSF supports early diagnosis of suspected Alzheimer's disease. The beta-amyloid (1-42)/beta-amyloid (1-40) ratio can improve the discrimination between Alzheimer's patients and vascular dementia.
- Alzheimer’s test
- CSF test for Alzheimer’s
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
1707898101.webp)
WhatsApp